United States · FDA National Drug Code directory

Protonix I.V.

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
0008-0923_a7e7d657-a748-4234-8dd6-c0e4d0f81a86
Product NDC
0008-0923
Form
INJECTION, POWDER, FOR SOLUTION
Composition / generic term
PANTOPRAZOLE SODIUM
Labeler
Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
Marketing category
NDA
Marketing start / end (source format)
20010501
Source listing expiry
20261231

Source-listed ingredients

  • PANTOPRAZOLE SODIUM — 40 mg/10mL

These values do not establish equivalence or a dose recommendation.

Packages

  • 1 VIAL in 1 CARTON (0008-0923-51) / 10 mL in 1 VIAL · 0008-0923-51
  • 10 CARTON in 1 PACKAGE (0008-0923-55) / 1 VIAL in 1 CARTON / 10 mL in 1 VIAL · 0008-0923-55
  • 25 CARTON in 1 PACKAGE (0008-0923-60) / 1 VIAL in 1 CARTON / 10 mL in 1 VIAL · 0008-0923-60

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
Protonix I.V. — United States | Molindra Medicines